• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BAXTER HEALTHCARE CORPORATION CLEARLINK/DUO-VENT; SET, ADMINISTRATION, INTRAVASCULAR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BAXTER HEALTHCARE CORPORATION CLEARLINK/DUO-VENT; SET, ADMINISTRATION, INTRAVASCULAR Back to Search Results
Model Number 2H7462
Device Problems Material Discolored (1170); Use of Device Problem (1670)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 11/30/2022
Event Type  malfunction  
Event Description
Since (b)(6) of 2022 (b)(6) has been noting discolored iv tubing from baxter, this has occurred with 4 different types of tubing sets.The discoloration impacts clinical practice as it makes it difficult for the rn administering the iv solution/medication to see the fluid in the tubing, assess for air bubbles, particulate, etc.Infection control and clinical staff have expressed concern utilizing the discolored tubing while caring for the institute's high-risk patient population as they fear the tubing is contaminated.The discoloration was reported to baxter and product return or exchange was requested, but refused.Baxter states the tubing is safe to use as discoloration is from the sterilization process.A letter from baxter was provided and attached to this report.However baxter has not provided additional details requested by (b)(6) leadership such as why only some sets are affected by the sterilization process, etc.(b)(6) has also noted there is now a disclaimer on some iv sets from baxter stating discolored sets are safe to use, but the disclaimer is not on all sets.2h7462 secondary tubing set known affected lots: r19i10108, r20g15033, r21k50079 and r21f16032.2,309 sets disposed.2r8538 primary tubing set known affected lots: dr21j30031, dr21i07062 and dr21l13024.588 cases quarantined at (b)(6) warehouse.2c8750 blood administration set: know affected lot; dr20i28040.52 sets disposed.2r8403 short primary set: no lot information available.158 sets disposed.Manufacturer response for iv tubing- short primary, (brand not provided) (per site reporter).Baxter declined offer to return affected product.Baxter states product is safe to use.Manufacturer response for iv tubing- blood administration set, (brand not provided) (per site reporter).Baxter declined offer to return affected product.Baxter states product is safe to use.Manufacturer response for iv tubing- primary set, (brand not provided) (per site reporter).Baxter declined offer to return affected product.Baxter states product is safe to use.Manufacturer response for iv tubing- secondary set, (brand not provided) (per site reporter).Baxter declined offer to return affected product.Baxter states product is safe to use.
 
Event Description
Since november of 2022 [redacted name] has been noting discolored iv tubing from baxter, this has occurred with 4 different types of tubing sets.The discoloration impacts clinical practice as it makes it difficult for the rn administering the iv solution/medication to see the fluid in the tubing, assess for air bubbles, particulate, etc.Infection control and clinical staff have expressed concern utilizing the discolored tubing while caring for the institute's high-risk patient population as they fear the tubing is contaminated.The discoloration was reported to baxter and product return or exchange was requested, but refused.Baxter states the tubing is safe to use as discoloration is from the sterilization process.A letter from baxter was provided and attached to this report.However baxter has not provided additional details requested by [redacted name] leadership such as why only some sets are affected by the sterilization process, etc.[redacted name] has also noted there is now a disclaimer on some iv sets from baxter stating discolored sets are safe to use, but the disclaimer is not on all sets.2h7462 secondary tubing set known affected lots: r19i10108, r20g15033, r21k50079, r21f16032, 2,309 sets disposed 2r8538 primary tubing set known affected lots: dr21j30031, dr21i07062, dr21l13024, 588 cases quarantined at [redacted name] 2c8750 blood administration set known affected lot; dr20i28040, 52 sets disposed 2r8403 short primary set no lot information available 158 sets disposed manufacturer response for iv tubing- short primary, (brand not provided) (per site reporter) baxter declined offer to return affected product.Baxter states product is safe to use.Manufacturer response for iv tubing- blood administration set, (brand not provided) (per site reporter) baxter declined offer to return affected product.Baxter states product is safe to use.Manufacturer response for iv tubing- primary set, (brand not provided) (per site reporter) baxter declined offer to return affected product.Baxter states product is safe to use.Manufacturer response for iv tubing- secondary set, (brand not provided) (per site reporter) baxter declined offer to return affected product.Baxter states product is safe to use.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
CLEARLINK/DUO-VENT
Type of Device
SET, ADMINISTRATION, INTRAVASCULAR
Manufacturer (Section D)
BAXTER HEALTHCARE CORPORATION
25212 w. illinois route 120
round lake IL 60073
MDR Report Key17388366
MDR Text Key319667692
Report Number17388366
Device Sequence Number1
Product Code FPA
Combination Product (y/n)N
Number of Events Reported1
Summary Report (Y/N)N
Report Source User Facility
Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date 07/24/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/25/2023
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Model Number2H7462
Device Catalogue Number2H7462
Device Lot NumberR19I10108,R20G15033,R21K50079
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Was the Report Sent to FDA? Yes
Date Report Sent to FDA07/24/2023
Event Location Hospital
Date Report to Manufacturer07/25/2023
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Unknown
Patient Sequence Number1
-
-